Actually, they reported this back in June in the annual report.

"The Company responded to the first ‘774 office action which was a rejection of certain claims by the patent office. In an effort to overcome the rejection, the Company filed a request to amend certain claim elements in the ‘774 patent, that was approved by the USPTO, thereby successfully ending the ‘774 reexamination. The Company expects, but cannot assure, that the amendments will help clarify and strengthen its ability to enforce infringement of the ‘774. "

So we continue to wait.